Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03220893 · ClinicalTrials.gov registry record · NA
Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 3,023
- Enrollment target
NCT03220893: Completed NA study, sponsored by Mayo Clinic.
NCT03220893 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 3,023 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03220893, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,023 participants
- Enrollment target
Study Summary
This study compares molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) in screening patients with dense breast tissue. Breast imaging may help doctors find breast cancer sooner, when it may be easier to treat. Molecular breast imaging (MBI) uses an injection of a small amount of radioactive material that is taken up in tissues of the body that are actively changing, such as breast cancer. A specialized camera, called a gamma camera, takes pictures of the gamma rays emitted by this material. MBI may detect cancers that are not visible on mammograms. This study may help researchers determine how MBI testing compares to DBT screening.
Interventions
- RADIATION Scintimammography
- PROCEDURE Digital Breast Tomosynthesis (DBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,023 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03220893
The ClinicalTrials.gov registry entry for NCT03220893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,023 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Scintimammography is the first listed.
NCT03220893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03220893 about?
NCT03220893 is a clinical study titled "Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue". This study compares molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) in screening patients with dense breast tissue. Breast imaging may help doctors find breast cancer sooner, when it may be easier to treat. Molecular breast imaging (MBI) uses an injection of a small amount of r...
What is the current status of trial NCT03220893?
This trial is currently completed. It is a NA study. The enrollment target is 3,023 participants. The study started on 2017-06-14. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT03220893?
The interventions under investigation include: Scintimammography (RADIATION), Digital Breast Tomosynthesis (DBT) (PROCEDURE).
Who is sponsoring clinical trial NCT03220893?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.